Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up
- PMID: 15800318
- DOI: 10.1200/JCO.2005.05.054
Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up
Abstract
Purpose: Many children diagnosed with retinoblastoma (Rb) survive into adulthood and are prone to subsequent cancers, particularly hereditary patients, who have germline Rb-1 mutations. We have extended the follow-up of a large cohort of Rb patients for 7 more years to provide new information on the risk of additional cancers after radiotherapy in long-term survivors.
Patients and methods: We analyzed the risk of new cancers through 2000 in 1,601 Rb survivors, diagnosed from 1914 to 1984, at two US medical centers. The standardized incidence ratio (SIR) was calculated as the ratio of the observed number of cancers after hereditary and nonhereditary Rb to the expected number from the Connecticut Tumor Registry. The cumulative incidence of a new cancer after hereditary and nonhereditary Rb and radiotherapy was calculated with adjustment for competing risk of death.
Results: Subsequent cancer risk in 963 hereditary patients (SIR, 19; 95% CI, 16 to 21) exceeded the risk in 638 nonhereditary Rb patients (SIR, 1.2; 95% CI, 0.7 to 2.0). Radiation further increased the risk of another cancer in hereditary patients by 3.1-fold (95% CI, 2.0 to 5.3). Hereditary patients continued to be at significantly increased risk for sarcomas, melanoma, and cancers of the brain and nasal cavities. The cumulative incidence for developing a new cancer at 50 years after diagnosis of Rb was 36% (95% CI, 31% to 41%) for hereditary and 5.7% (95% CI, 2.4% to 11%) for nonhereditary patients.
Conclusion: Hereditary Rb predisposes to a variety of new cancers over time, with radiotherapy further enhancing the risk of tumors arising in the radiation field.
Similar articles
-
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. doi: 10.1093/jnci/djn394. Epub 2008 Dec 9. J Natl Cancer Inst. 2008. PMID: 19066271
-
Cancer mortality in long-term survivors of retinoblastoma.Eur J Cancer. 2009 Dec;45(18):3245-53. doi: 10.1016/j.ejca.2009.05.011. Epub 2009 Jun 1. Eur J Cancer. 2009. PMID: 19493675
-
Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.J Natl Cancer Inst. 2007 Jan 3;99(1):24-31. doi: 10.1093/jnci/djk002. J Natl Cancer Inst. 2007. PMID: 17202110
-
[Retinoblatoma: a review].Arch Pediatr. 2006 Oct;13(10):1329-37. doi: 10.1016/j.arcped.2006.06.017. Epub 2006 Aug 23. Arch Pediatr. 2006. PMID: 16930963 Review. French.
-
[Radiation-induced cancers following radiotherapy].Gan To Kagaku Ryoho. 1999 Nov;26(13):2015-20. Gan To Kagaku Ryoho. 1999. PMID: 10584565 Review. Japanese.
Cited by
-
Genetic Predisposition to Sarcoma: What Should Clinicians Know?Curr Treat Options Oncol. 2024 Jun;25(6):769-783. doi: 10.1007/s11864-024-01192-6. Epub 2024 May 7. Curr Treat Options Oncol. 2024. PMID: 38713268 Review.
-
Incidence of second primary cancers in patients with retinoblastoma: a systematic review and meta-analysis.Front Oncol. 2024 Mar 28;14:1372548. doi: 10.3389/fonc.2024.1372548. eCollection 2024. Front Oncol. 2024. PMID: 38606112 Free PMC article.
-
Susceptibility Genes Associated with Multiple Primary Cancers.Cancers (Basel). 2023 Dec 10;15(24):5788. doi: 10.3390/cancers15245788. Cancers (Basel). 2023. PMID: 38136334 Free PMC article. Review.
-
An Interesting Case of Post-enucleation Retinoblastoma Presenting With Distant Liver and Skeletal Metastases Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography.Cureus. 2023 Nov 4;15(11):e48249. doi: 10.7759/cureus.48249. eCollection 2023 Nov. Cureus. 2023. PMID: 38054123 Free PMC article.
-
Risk of Second Tumors in Retinoblastoma Survivors after Ionizing Radiation: A Review.Cancers (Basel). 2023 Nov 9;15(22):5336. doi: 10.3390/cancers15225336. Cancers (Basel). 2023. PMID: 38001596 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous